Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

2009/041 NICE Welcomes New Non-Executive Director To Its Board
The National Institute for Health and Clinical Excellence (NICE) is pleased to announce a new non-executive member to its Board. Andy McKeon replaces Mark Taylor who stood down in April. Andy is Managing Director Health at the Audit Commission and is responsible for all the Commission"s work in the NHS and on health matters. Prior to that he was Director of Policy and Planning at the Department of Health (DH) with oversight of the policy agenda for the reform and improvement of health and social care. This also included responsibility for target setting and for the associated planning and reporting systems. His post also covered all aspects of pharmaceuticals and pharmacy and the clinical and cost effective use of medicines in the NHS.
generic viagra online
PerkinElmer Introduces Infrared Sensing And Photon Detection Solutions For Critical Environmental And Human Health Applications
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced the introduction of four new products leveraging the Company"s innovative infrared sensing (IR) and photon detection technologies. Aimed at a range of OEM applications including energy conservation, enhanced home security, and clinical diagnostics applications, the new products will be showcased at the 16th annual Sensor + Test Fair taking place this week in NÃørnberg, Germany.
News of the day
Global Lupus Experts Gather For Historic Meeting -- Urgent And Unmet Needs Of Individuals With Lupus Dominate Agenda
The Lupus Foundation of America (LFA) convened an Expert Panel June 1-2 to address the urgent and unmet need for the development and approval of new, safe, effective, and tolerable medications for people with lupus. It has been more than 50 years since the U.S. Food and Drug Administration (FDA) approved a new drug specifically to treat lupus. Discussions during the two-day meeting in Washington, DC focused on how to better conduct studies of potential new lupus treatments, including clinical endpoints, diagnostic tools, background medications, and clinical trial design.
Oncology

Advances In Stem Cell Research: New Interdisciplinary Volume

In a variety of organisms, from zebrafish to fruit flies to humans, stem cells have the potential to differentiate into a variety of tissues--and, in some cases, to give rise to a complete new organism. Stem cell research, therefore, has attracted the attention of a range of biologists--reproductive biologists, cancer biologists, cell and developmental biologists, and others--who have all recognized its importance and therapeutic potential. A new book from Cold Spring Harbor Laboratory Press, Control and Regulation of Stem Cells, reviews the latest advances in stem cell research from a variety of scientific perspectives. Chapters in the book are based on presentations by world-renowned investigators at the 73rd annual Cold Spring Harbor Symposium on Quantitative Biology at Cold Spring Harbor Laboratory, which was attended by 465 scientists from more than 30 countries. "Progress in stem cell research is now extremely intense," wrote the meeting organizers, Bruce Stillman, David Stewart, and Terri Grodzicker, in the Foreword to the book. "It therefore seemed appropriate to focus the 73rd Symposium on this important and rapidly developing field, providing a unique synthesis of the exciting progress being made in the field of stem cell biology, not only for the Symposia attendees, but for a wider global audience via interviews freely available on the world wide web, and, we anticipate, for readers of these Proceedings." The book is divided into ten sections, each with 5-8 chapters on a specific topic: Germ Cells and Totipotency, Niches and Asymmetry, Embryonic Development and Multipotent Progenitors, Reprogramming Somatic Cells, Gene Expression and Transcriptional Networks, Epigenetics, Adult Stem Cells, Neural Stem Cells and Brain Tumors, Stem Cells and Cancer, and Renewal and Regeneration. The book concludes with a summary of the field, and includes a discussion of future challenges for translating basic research into clinical applications. Control and Regulation of Stem Cells is also available online (http://www.cshl-symposium.org). Libraries that purchase the hardcover edition are entitled to unlimited web access to it for their students and staff. Interviews with various speakers from the symposium are at http://meetings.cshl.edu/chats/symposium08/. Notes: About the book - Control and Regulation of Stem Cells (Cold Spring Harbor Symposia on Quantitative Biology Volume LXXIII) was published by Cold Spring Harbor Laboratory Press (© 2008). It is available in paperback (ISBN 978-087969862-1) and hardcover (ISBN 978-087969861-4), is 614 pp. in length, and includes illustrations and author and subject indexes. For additional information, please see http://www.cshlpress.com/link/conregstemp.htm. Ingrid Benirschke Cold Spring Harbor Laboratory


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009